SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2019-04-22 10:45
Tx date 2019-04-17
$CMTA
Clementia Pharmaceuticals Inc.
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
59 - Exercise for cash
$-298,375
-11,935 vol
$25.00 each
0
Filed 2019-04-22 10:44
Tx date 2019-04-17
$CMTA
Clementia Pharmaceuticals Inc.
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
Options
59 - Exercise for cash

-142,681 vol
0
Filed 2019-04-22 10:43
Tx date 2019-04-17
$CMTA
Clementia Pharmaceuticals Inc.
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
$-1,468,775
-58,751 vol
$25.00 each
0
Filed 2019-03-01
Tx date 2019-02-24
$CMTA
Clementia Pharmaceuticals Inc.
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights

+7,845 vol
11,935
Filed 2019-01-04
Tx date 2018-12-31
$CMTA
Clementia Pharmaceuticals Inc.
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights

+1,062 vol
4,090
Filed 2018-11-29
Tx date 2018-11-06
$CMTA
Clementia Pharmaceuticals Inc.
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+11,990 vol
142,681
Filed 2018-10-04
Tx date 2018-09-30
$CMTA
Clementia Pharmaceuticals Inc.
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights

+1,121 vol
3,028
Filed 2018-07-04
Tx date 2018-06-30
$CMTA
Clementia Pharmaceuticals Inc.
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights

+1,021 vol
1,907
Filed 2018-04-17
Tx date 2018-03-31
$CMTA
Clementia Pharmaceuticals Inc.
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights

+886 vol
886
Filed 2018-04-17
Tx date 2017-08-14
$CMTA
Clementia Pharmaceuticals Inc.
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
Filed 2018-04-17
Tx date 2017-08-14
$CMTA
Clementia Pharmaceuticals Inc.
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
Filed 2018-04-17
Tx date 2017-08-14
$CMTA
Clementia Pharmaceuticals Inc.
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
Filed 2018-04-17
Tx date 2018-03-31
$CMTA
Clementia Pharmaceuticals Inc.
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights

+886 vol
Filed 2018-04-17
Tx date 2018-03-31
$CMTA
Clementia Pharmaceuticals Inc.
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights

+886 vol
Filed 2018-04-16
Tx date 2017-08-14
$CMTA
Clementia Pharmaceuticals Inc.
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
00 - Opening Balance-Initial SEDI Report
Filed 2018-04-16
Tx date 2018-03-31
$CMTA
Clementia Pharmaceuticals Inc.
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
Rights DSU (Deferred Share Units)
56 - Grant of rights

+886 vol
886
Filed 2017-08-23
Tx date 2017-08-14
$CMTA
Clementia Pharmaceuticals Inc.
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
58,751
Filed 2017-08-23
Tx date 2017-08-14
$CMTA
Clementia Pharmaceuticals Inc.
Mandelzys, Allan
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
130,691